Despite the withdrawal of an investor, Langhorne-based Nexgel successfully finalized its acquisition of Celularity’s ...

Hypoxia, or local lack of oxygen, which develops in aggressive cancer tumors is one of the main obstacles to the ...

Buck County firm Nexgel pulled off a "three-team trade" to acquire six new products, picking up three additional assets in ...

Collaboration with leading European orthopedic center in Italy supports GelrinC® clinical adoptionRenowned cartilage ...

Collaboration with leading European orthopedic center in Italy supports GelrinC clinical adoptionRenowned cartilage ...

$7.4 million in cash expected to provide runway to complete site expansion process and patient enrollment as part of pivotal Phase III FDA trial for GelrinC Already approved in Europe, GelrinC is ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Matthew Guay More than almost any other category, journaling software is about ...

HUNTSVILLE, ALABAMA / ACCESS Newswire / November 13, 2025 / Curiteva, Inc. a privately held manufacturing and technology company, proudly announces the publication of a peer-reviewed study, "Novel ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The Editor's Feature emphasizes high-quality collections that have been developed in our journal each month. This Research Topic has been acknowledged by the Specialty Chief Editor of the Biomaterials ...

Heart valve disease contributes to cardiovascular disease–associated death. Bioprosthetic heart valves have emerged as a preferred option for heart valve replacement due to their superior hemodynamic ...